Page last updated: 2024-11-06

triethylenemelamine and Chronic Pain

triethylenemelamine has been researched along with Chronic Pain in 1 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konno, SI1
Alev, L1
Oda, N1
Ochiai, T1
Enomoto, H1

Trials

1 trial available for triethylenemelamine and Chronic Pain

ArticleYear
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
    Pain medicine (Malden, Mass.), 2019, 08-01, Volume: 20, Issue:8

    Topics: Adult; Aged; Analgesics; Chronic Pain; Constipation; Duloxetine Hydrochloride; Female; Humans; Japan

2019